825 related articles for article (PubMed ID: 32512122)
21. The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study.
Mangion K; Morrow A; Bagot C; Bayes H; Blyth KG; Church C; Corcoran D; Delles C; Gillespie L; Grieve D; Ho A; Kean S; Lang NN; Lennie V; Lowe DJ; Kellman P; Macfarlane PW; McConnachie A; Roditi G; Sykes R; Touyz RM; Sattar N; Wereski R; Wright S; Berry C
Cardiovasc Res; 2020 Dec; 116(14):2185-2196. PubMed ID: 32702087
[TBL] [Abstract][Full Text] [Related]
22. "When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review.
Kounis NG; Gogos C; de Gregorio C; Hung MY; Kounis SN; Tsounis EP; Assimakopoulos SF; Pourmasumi S; Mplani V; Servos G; Dousdampanis P; Plotas P; Michalaki MA; Tsigkas G; Grammatikopoulos G; Velissaris D; Koniar I
Balkan Med J; 2024 Jan; 41(1):7-22. PubMed ID: 38173173
[TBL] [Abstract][Full Text] [Related]
23. Myocardial injury and COVID-19: Possible mechanisms.
Babapoor-Farrokhran S; Gill D; Walker J; Rasekhi RT; Bozorgnia B; Amanullah A
Life Sci; 2020 Jul; 253():117723. PubMed ID: 32360126
[TBL] [Abstract][Full Text] [Related]
24. Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.
Ruzzenenti G; Maloberti A; Giani V; Biolcati M; Leidi F; Monticelli M; Grasso E; Cartella I; Palazzini M; Garatti L; Ughi N; Rossetti C; Epis OM; Giannattasio C;
High Blood Press Cardiovasc Prev; 2021 Sep; 28(5):439-445. PubMed ID: 34173942
[TBL] [Abstract][Full Text] [Related]
25. Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19.
Melillo F; Napolano A; Loffi M; Regazzoni V; Boccellino A; Danzi GB; Cappelletti AM; Rovere-Querini P; Landoni G; Ingallina G; Stella S; Ancona F; Dagna L; Scarpellini P; Ripa M; Castagna A; Tresoldi M; Zangrillo A; Ciceri F; Agricola E
Eur J Clin Invest; 2022 Jan; 52(1):e13703. PubMed ID: 34706062
[TBL] [Abstract][Full Text] [Related]
26. Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection.
Robinson FA; Mihealsick RP; Wagener BM; Hanna P; Poston MD; Efimov IR; Shivkumar K; Hoover DB
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1059-H1068. PubMed ID: 33036546
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review.
Gordon JS; Drazner MH
Curr Heart Fail Rep; 2021 Jun; 18(3):163-168. PubMed ID: 33666855
[TBL] [Abstract][Full Text] [Related]
28. Covid-19 and the cardiovascular system: a comprehensive review.
Azevedo RB; Botelho BG; Hollanda JVG; Ferreira LVL; Junqueira de Andrade LZ; Oei SSML; Mello TS; Muxfeldt ES
J Hum Hypertens; 2021 Jan; 35(1):4-11. PubMed ID: 32719447
[TBL] [Abstract][Full Text] [Related]
29. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
Rossouw TM; Anderson R; Manga P; Feldman C
Front Immunol; 2022; 13():776861. PubMed ID: 35185878
[TBL] [Abstract][Full Text] [Related]
30. Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience.
De Michieli L; Babuin L; Vigolo S; Berti De Marinis G; Lunardon A; Favretto F; Lobo R; Sandoval Y; Bryant SC; Donato D; Plebani M; Vettor R; Iliceto S; Cianci V; Jaffe AS
Clin Biochem; 2021 Apr; 90():8-14. PubMed ID: 33529580
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 and Acute Cardiac Injury: Clinical Manifestations, Biomarkers, Mechanisms, Diagnosis, and Treatment.
Qiu H; Li J; Li J; Li H; Xin Y
Curr Cardiol Rep; 2023 Aug; 25(8):817-829. PubMed ID: 37314650
[TBL] [Abstract][Full Text] [Related]
32. High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19.
De Michieli L; Ola O; Knott JD; Akula A; Mehta RA; Hodge DO; Dworak M; Yang EH; Gharacholou M; Singh G; Singh R; Gulati R; Jaffe AS; Sandoval Y
Clin Chem; 2021 Aug; 67(8):1080-1089. PubMed ID: 33860295
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges.
Manolis AS; Manolis AA; Manolis TA; Melita H
J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):399-414. PubMed ID: 33949887
[TBL] [Abstract][Full Text] [Related]
34. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis.
Calvo-Fernández A; Izquierdo A; Subirana I; Farré N; Vila J; Durán X; García-Guimaraes M; Valdivielso S; Cabero P; Soler C; García-Ribas C; Rodríguez C; Llagostera M; Mojón D; Vicente M; Solé-González E; Sánchez-Carpintero A; Tevar C; Marrugat J; Vaquerizo B
Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):576-583. PubMed ID: 33153955
[TBL] [Abstract][Full Text] [Related]
35. Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study.
Gorecka M; McCann GP; Berry C; Ferreira VM; Moon JC; Miller CA; Chiribiri A; Prasad S; Dweck MR; Bucciarelli-Ducci C; Dawson D; Fontana M; Macfarlane PW; McConnachie A; Neubauer S; Greenwood JP;
J Cardiovasc Magn Reson; 2021 Jun; 23(1):77. PubMed ID: 34112195
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
Bojkova D; Wagner JUG; Shumliakivska M; Aslan GS; Saleem U; Hansen A; Luxán G; Günther S; Pham MD; Krishnan J; Harter PN; Ermel UH; Frangakis AS; Milting H; Zeiher AM; Klingel K; Cinatl J; Dendorfer A; Eschenhagen T; Tschöpe C; Ciesek S; Dimmeler S
Cardiovasc Res; 2020 Dec; 116(14):2207-2215. PubMed ID: 32966582
[TBL] [Abstract][Full Text] [Related]
37. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.
Amendola A; Garoffolo G; Songia P; Nardacci R; Ferrari S; Bernava G; Canzano P; Myasoedova V; Colavita F; Castilletti C; Sberna G; Capobianchi MR; Piacentini M; Agrifoglio M; Colombo GI; Poggio P; Pesce M
Cardiovasc Res; 2021 May; 117(6):1557-1566. PubMed ID: 33705542
[TBL] [Abstract][Full Text] [Related]
38. Cardiac manifestations of COVID-19 in Shenzhen, China.
Zeng JH; Wu WB; Qu JX; Wang Y; Dong CF; Luo YF; Zhou D; Feng WX; Feng C
Infection; 2020 Dec; 48(6):861-870. PubMed ID: 32725595
[TBL] [Abstract][Full Text] [Related]
39. Cardiac biomarkers alterations in patients with SARS-CoV-2 infection.
Oikonomou E; Paraskevas T; Velissaris D
Rom J Intern Med; 2022 Mar; 60(1):6-13. PubMed ID: 34610232
[TBL] [Abstract][Full Text] [Related]
40. Use and Prognostic Implications of Cardiac Troponin in COVID-19.
De Michieli L; Jaffe AS; Sandoval Y
Cardiol Clin; 2022 Aug; 40(3):287-300. PubMed ID: 35851452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
